Jennifer Wiggins

1.4k total citations
36 papers, 820 citations indexed

About

Jennifer Wiggins is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Jennifer Wiggins has authored 36 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in Jennifer Wiggins's work include Cancer Genomics and Diagnostics (11 papers), BRCA gene mutations in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jennifer Wiggins is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), BRCA gene mutations in cancer (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jennifer Wiggins collaborates with scholars based in United States, United Kingdom and Australia. Jennifer Wiggins's co-authors include Joann Peck, Dietmar W. Siemann, Pamela E. Grimm, Bradley J. Behnke, David Polsky, Stephen Preece, Samantha S. Dykes, Mai Tanaka, Eduard Gasal and Michael A. Davies and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Marketing.

In The Last Decade

Jennifer Wiggins

35 papers receiving 785 citations

Peers

Jennifer Wiggins
William R. Wilson United States
Laura Bradley United Kingdom
James M. Hunt United States
Simon Wong Hong Kong
Maria Agthe Germany
Shuzo Abe Japan
Michael T. Lee United States
Mike Yao United States
William R. Wilson United States
Jennifer Wiggins
Citations per year, relative to Jennifer Wiggins Jennifer Wiggins (= 1×) peers William R. Wilson

Countries citing papers authored by Jennifer Wiggins

Since Specialization
Citations

This map shows the geographic impact of Jennifer Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Wiggins more than expected).

Fields of papers citing papers by Jennifer Wiggins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Wiggins. The network helps show where Jennifer Wiggins may publish in the future.

Co-authorship network of co-authors of Jennifer Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Wiggins. A scholar is included among the top collaborators of Jennifer Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Wiggins. Jennifer Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ain, Quratul, Rachel O’Connell, Terri McVeigh, et al.. (2024). Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation. European Journal of Surgical Oncology. 51(3). 109380–109380. 1 indexed citations
3.
Wiggins, Jennifer, et al.. (2024). Legitimate incongruity: Strategic positioning within hybrid categories. Journal of Business Venturing. 39(4). 106402–106402. 3 indexed citations
4.
Wiggins, Jennifer, Hao Tang, Keyur Desai, et al.. (2023). Association of circulating tumor DNA kinetics with disease recurrence in patients with stage IIIB/C/IV melanoma treated with adjuvant immunotherapy in Checkmate 238.. Journal of Clinical Oncology. 41(16_suppl). 9577–9577. 3 indexed citations
6.
Wiggins, Jennifer, et al.. (2022). Cell-Free DNA in Dermatology Research. Journal of Investigative Dermatology. 142(6). 1523–1528.e1. 5 indexed citations
7.
Wiggins, Jennifer, et al.. (2022). Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria. Scientific Reports. 12(1). 2507–2507. 8 indexed citations
8.
Chang, Gregory, Eric M. Robinson, Jennifer Wiggins, et al.. (2022). Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort. Journal of Investigative Dermatology. 142(10). 2733–2743.e9. 8 indexed citations
9.
Wiggins, Jennifer, Georgina V. Long, Keith T. Flaherty, et al.. (2021). Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. The Lancet Oncology. 22(3). 370–380. 70 indexed citations
10.
Chang, Gregory, Jennifer Wiggins, Nathaniel H. Fleming, et al.. (2020). TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors. Journal of Investigative Dermatology. 140(8). 1609–1618.e7. 14 indexed citations
11.
Wiggins, Jennifer, Sylvia C. Kurz, Dimitris G. Placantonakis, et al.. (2020). Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patients. Clinical Cancer Research. 26(11_Supplement). A65–A65. 1 indexed citations
12.
Wiggins, Jennifer, et al.. (2019). Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma. Methods in molecular biology. 2055. 155–180. 9 indexed citations
13.
Lønbro, Simon, Jennifer Wiggins, Thomas R. Wittenborn, et al.. (2019). Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLoS ONE. 14(5). e0215584–e0215584. 29 indexed citations
14.
Wiggins, Jennifer, Sylvia C. Kurz, Dimitris G. Placantonakis, et al.. (2019). Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using TERT promoter mutation-specific droplet digital PCR assays.. Journal of Clinical Oncology. 37(15_suppl). 2026–2026. 11 indexed citations
15.
Wiggins, Jennifer, et al.. (2018). “My Brand” Behaved Badly: Psychological Ownership and Consumer Responsibility For Helping Brands Recover From Transgressions. ACR North American Advances. 1 indexed citations
16.
Dykes, Samantha S., et al.. (2018). Stromal cells in breast cancer as a potential therapeutic target. Oncotarget. 9(34). 23761–23779. 30 indexed citations
17.
Wiggins, Jennifer, et al.. (2018). Tumor oxygenation and cancer therapy—then and now. British Journal of Radiology. 92(1093). 20170955–20170955. 47 indexed citations
18.
Cui, Annie Peng & Jennifer Wiggins. (2017). What You Ask Changes What I Pay: Framing Effects in Pay What You Want Pricing. The Journal of Marketing Theory and Practice. 25(4). 323–339. 7 indexed citations
19.
Goldar, Arach, et al.. (2015). Tight Chk1 Levels Control Replication Cluster Activation in Xenopus. PLoS ONE. 10(6). e0129090–e0129090. 10 indexed citations
20.
Middleton, Anna, et al.. (2014). Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland). European Journal of Human Genetics. 22(8). 955–956. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026